Abstract
Multi-drug-resistant Escherichia coli poses a great threat to human health. E. coli is often used as fecal indicator bacteria to study the sources and fate of fecal contamination in the environment. This study focused on water and soil samples in tourist parks around Kadamaian, Kota Belud from three different villages of Kampung Napungguk, Kampung Pinalabuh and Kampung Tinata. From 23 of tested presumptive E. coli isolates, the percentage of antimicrobial-resistant against a series of antibiotic concentrations ranging from 25, 50, 100 to 500 μg/ml showed resistance towards Chloramphenicol (91.3%), Penicillin (82.6%), Tetracycline (73.9%) and Kanamycin (30.43%). This finding suggested the presence of multi-drug resistance (MDR) of presumptive E. coli from soil samples of Kampung Napungguk and Kampung Tinata. This study alarms the presence of MDR which need further research on identifying the bacterial strains using molecular methods. The findings can then be used to create awareness of potential disease outbreaks in the tourist areas.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.